This study focuses on validating and testing three proinflammatory chemokines, CCL2, CCL18, and CXCL10, previously identified by SomaScan® analysis, as being elevated in serum samples of glucocorticoid naïve DMD patients compared to age-matched healthy controls [3]. The gene discussed is CCL2; the disease is Duchenne muscular dystrophy.